Hsin‐Lun Lee

836 total citations
48 papers, 545 citations indexed

About

Hsin‐Lun Lee is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hsin‐Lun Lee has authored 48 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Hsin‐Lun Lee's work include Nanoplatforms for cancer theranostics (6 papers), Medical Imaging Techniques and Applications (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Hsin‐Lun Lee is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Medical Imaging Techniques and Applications (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Hsin‐Lun Lee collaborates with scholars based in Taiwan, United States and Japan. Hsin‐Lun Lee's co-authors include Jeng‐Fong Chiou, Chun‐Chieh Chen, Chuen‐Horng Lin, Jan‐Ray Liao, Lai‐Lei Ting, Yao-Chen Chuang, Yao Shen, Jeng-Fong Chiou, Jo‐Ting Tsai and Shang-Wen Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bone and Joint Surgery and ACS Applied Materials & Interfaces.

In The Last Decade

Hsin‐Lun Lee

41 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsin‐Lun Lee Taiwan 13 185 145 135 98 77 48 545
Shayan Nazari United States 8 149 0.8× 88 0.6× 143 1.1× 99 1.0× 74 1.0× 16 471
Yunchao Deng China 12 154 0.8× 110 0.8× 255 1.9× 110 1.1× 43 0.6× 26 530
Minghua Ge China 15 186 1.0× 112 0.8× 270 2.0× 112 1.1× 85 1.1× 51 734
Qingyi Liu China 9 189 1.0× 91 0.6× 128 0.9× 79 0.8× 29 0.4× 24 423
Chia-Chun Kuo Taiwan 10 95 0.5× 111 0.8× 110 0.8× 58 0.6× 38 0.5× 18 390
Heinz-J. Buhr Germany 9 298 1.6× 101 0.7× 225 1.7× 119 1.2× 66 0.9× 11 562
Yongbiao Huang China 13 127 0.7× 106 0.7× 177 1.3× 86 0.9× 43 0.6× 41 448

Countries citing papers authored by Hsin‐Lun Lee

Since Specialization
Citations

This map shows the geographic impact of Hsin‐Lun Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsin‐Lun Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsin‐Lun Lee more than expected).

Fields of papers citing papers by Hsin‐Lun Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsin‐Lun Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsin‐Lun Lee. The network helps show where Hsin‐Lun Lee may publish in the future.

Co-authorship network of co-authors of Hsin‐Lun Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Hsin‐Lun Lee. A scholar is included among the top collaborators of Hsin‐Lun Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsin‐Lun Lee. Hsin‐Lun Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Ming‐Shun, Wei‐Yu Kao, Shih–Jer Hsu, et al.. (2025). Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation. Liver Cancer. 15(1). 149–164.
2.
Chang, Wei‐Min, Chia-Yu Wu, Hsin‐Lun Lee, et al.. (2025). EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis. Neoplasia. 66. 101193–101193. 1 indexed citations
3.
Chiu, Hui‐Wen, et al.. (2024). AIM2 promotes irradiation resistance, migration ability and PD-L1 expression through STAT1/NF-κB activation in oral squamous cell carcinoma. Journal of Translational Medicine. 22(1). 13–13. 13 indexed citations
4.
Kao, Wei‐Yu, Elise Chia‐Hui Tan, Hsin‐Lun Lee, et al.. (2023). Entecavir versus tenofovir on prognosis of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy. Alimentary Pharmacology & Therapeutics. 57(11). 1299–1312. 8 indexed citations
5.
Ho, Wan‐Ling, et al.. (2023). Multidisciplinary team approach for Klippel-Trenaunay syndrome: A case series. Pediatrics & Neonatology. 64(3). 341–343.
7.
Lee, Hsin‐Lun, et al.. (2023). Frontier Review of the Molecular Mechanisms and Current Approaches of Stem Cell-Derived Exosomes. Cells. 12(7). 1018–1018. 18 indexed citations
8.
Tsai, Jo‐Ting, Her‐Shyong Shiah, Hsuan‐Yu Chen, et al.. (2023). Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression. Diagnostics. 13(9). 1597–1597. 1 indexed citations
9.
Chang, Po‐Ling, et al.. (2023). The Titrated Mannitol Improved Central [99mTc] Tc TRODAT-1 Uptake in an Animal Model—A Clinically Feasible Application. International Journal of Molecular Sciences. 24(4). 3773–3773.
10.
Lee, Hsun‐Hua, et al.. (2023). NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma. Cancer Cell International. 23(1). 41–41. 7 indexed citations
11.
Chuang, Yao-Chen, et al.. (2023). Recent Advances in Metal-Based NanoEnhancers for Particle Therapy. Nanomaterials. 13(6). 1011–1011. 12 indexed citations
12.
Hsu, Fang‐Chi, Hsin‐Lun Lee, Yin‐Ju Chen, et al.. (2022). A Few-Shot Learning Approach Assists in the Prognosis Prediction of Magnetic Resonance-Guided Focused Ultrasound for the Local Control of Bone Metastatic Lesions. Cancers. 14(2). 445–445. 7 indexed citations
14.
Yang, Bang‐Hung, et al.. (2022). Very-Low-Dose Radiation and Clinical Molecular Nuclear Medicine. Life. 12(6). 912–912. 5 indexed citations
15.
Lin, Kuan‐Chou, Lai‐Lei Ting, Chia‐Lun Chang, et al.. (2021). Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer. Cancers. 13(23). 6076–6076. 31 indexed citations
16.
Lee, Hsin‐Lun, Jeng-Fong Chiou, Peng‐Yuan Wang, et al.. (2020). Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung Cancer. Cancers. 12(11). 3394–3394. 33 indexed citations
17.
Lee, Hsin‐Lun, Jo‐Ting Tsai, Ying‐Chun Lin, et al.. (2019). Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization. Therapeutic Advances in Medical Oncology. 11. 3862504042–3862504042. 5 indexed citations
18.
Lai, Gi‐Ming, Jyh‐Ming Chow, Yumei Zheng, et al.. (2018). Opposite Regulation of CHOP and GRP78 and Synergistic Apoptosis Induction by Selenium Yeast and Fish Oil via AMPK Activation in Lung Adenocarcinoma Cells. Nutrients. 10(10). 1458–1458. 7 indexed citations
19.
Hsiao, Shih-Hsin, Sey‐En Lin, Yu‐Ting Chou, et al.. (2013). Histological subtype and smoking status, but not gender, are associated with epidermal growth factor receptor mutations in non-small-cell lung cancer. Molecular and Clinical Oncology. 2(2). 252–258. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026